Yaqrit is a clinical-stage company discovering and developing treatments for patients with advanced liver disease.
Yaqrit has raised $2.8M in total funding. The most recent round was Grant. The last funding was announced in March 2025.
Yaqrit's investors include National Institute for Health and Care Research, Horizon 2020, UCLB, Trend Investment Group, Riveria Investment Group.
Yaqrit is headquartered in London, United Kingdom.
Yaqrit is a clinical-stage company discovering and developing treatments for patients with advanced liver disease.
Yaqrit is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Yaqrit — Funding & Investors." VCBacked, March 21, 2025, https://www.vcbacked.co/company/yaqrit. Accessed September 30, 2026.
VCBacked. (2025). Yaqrit — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/yaqrit
{{cite web |title=Yaqrit — Funding & Investors |url=https://www.vcbacked.co/company/yaqrit |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated